The validity of biochemical markers in metabolic bone disease in preterm infants: a systematic review.
To establish the validity of biochemical markers of metabolic bone disease (MBD) in preterm infants. There is insufficient evidence that any of the frequently used serum measurements are valid biochemical markers of MBD in preterm infants. Increased urinary calcium concentration may be a valid biochemical marker, but more research is necessary to confirm this.